Reduced expiratory variability index (EVI) is associated with controller medication withdrawal and symptoms in wheezy children aged 1-5 years.
Ville-Pekka SeppäMarita PaassiltaJuho KivistöAnton HultJari ViikJavier Gracia-TabuencaJussi KarjalainenPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2020)
EVI was lower in patients than in controls and it reduced further after controller medication withdrawal, especially in the presence of parentally perceived wheeze symptoms. This technique shows a significant potential for routine lung function testing of wheezy young children.
Keyphrases
- lung function
- end stage renal disease
- cystic fibrosis
- ejection fraction
- newly diagnosed
- healthcare
- chronic obstructive pulmonary disease
- air pollution
- chronic kidney disease
- prognostic factors
- young adults
- physical activity
- depressive symptoms
- emergency department
- mental health
- adverse drug
- clinical practice
- risk assessment
- patient reported outcomes